Direxion Daily S&P Biotech Bear 1X ETF (LABS) Analysis
本页由 AI 从英文原文机器翻译而来；以英文版本为准。 阅读英文版本
仅供参考。不构成财务建议。
Direxion Daily S&P Biotech Bear 1X ETF (LABS) ETF — Price, Holdings & Analysis
ETF 概览
Direxion Daily S&P Biotech Bear 1X ETF provides exposure to the equity market. Direxion Daily S&P Biotech Bear 1X ETF invests across equity markets, providing investors with diversified exposure to this asset class through a single, exchange-traded vehicle. As an exchange-traded fund, it offers the benefits of intraday liquidity, transparent holdings, and generally lower costs compared to traditional mutual fund structures.
风险指标
As with all ETFs, the fund is subject to market risk and its value will fluctuate with market conditions. Past performance does not guarantee future results. The fund's investment objectives, risks, charges, and expenses may be worth researching before investing.
- ARK Innovation ETF (ARKK) — 0.75% expense ratio
- Invesco QQQ Trust, Series 1 (QQQ) — 0.18% expense ratio
- State Street Energy Select Sector SPDR ETF (XLE) — 0.08% expense ratio
- State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) — 0.16% expense ratio
- State Street Technology Select Sector SPDR ETF (XLK) — 0.08% expense ratio
- WisdomTree Emerging Markets ESG Fund (DVEM) — 0.32% expense ratio
- Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) — 0.59% expense ratio
- iShares MSCI EAFE ETF (EFA) — 0.32% expense ratio
- Direxion Daily AMD Bull 2X ETF (AMUU) (Equity) — 1.16% expense ratio
- Direxion Daily Global Clean Energy Bull 2X Shares (KLNE) (Equity) — 1.33% expense ratio
- Direxion MSCI Developed Over Emerging Markets ETF (RWDE) (Equity) — 0.53% expense ratio
- Direxion Daily Uranium Industry Bull 2X ETF (URAA) (Equity) — 1.46% expense ratio
- Direxion Russell Small Over Large Cap ETF (RWSL) (Equity) — 0.59% expense ratio
- Direxion Daily XOM Bull 2X ETF (XOMX) (Equity) — 2.36% expense ratio
常见问题
How long has LABS been around?
Direxion Daily S&P Biotech Bear 1X ETF was launched in 2015, making it 11 years old. With over a decade of history, it has navigated various market conditions.
Is LABS a good investment?
Direxion Daily S&P Biotech Bear 1X ETF is a equity ETF. Equity ETFs are subject to market risk and can experience significant short-term volatility, though they have historically provided strong long-term returns for patient investors.
Whether it is suitable depends on your investment goals, risk tolerance, and time horizon. Consider consulting a financial advisor for personalized guidance.
免责声明：本内容仅供参考，不构成投资建议。请始终自行研究并咨询专业财务顾问。
数据仅供参考。
本页由机器撰写，未逐页经过人工审阅。编辑把关是系统性的：我们检查规则与数据来源，但不检查每一个页面。